PT Nanotech Indonesia Global Tbk (IDX:NANO)
Indonesia · Delayed Price · Currency is IDR 22.00
-2.00 (-8.33%)
Jun 23, 2026, 1:36 PM WIB
IDX:NANO Revenue
In the year 2025, PT Nanotech Indonesia Global Tbk had annual revenue of 72.17B IDR, down -37.17%. PT Nanotech Indonesia Global Tbk had revenue of 19.67B in the half year ending December 31, 2025, a decrease of -67.93%.
Revenue
72.17B
Revenue Growth
-37.17%
P/S Ratio
1.43
Revenue / Employee
4.25B
Employees
17
Market Cap
102.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.17B | -42.70B | -37.17% |
| Dec 31, 2024 | 114.86B | 31.04B | 37.03% |
| Dec 31, 2023 | 83.82B | 39.12B | 87.50% |
| Dec 31, 2022 | 44.70B | 17.93B | 66.97% |
| Dec 31, 2021 | 26.77B | 10.73B | 66.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 36.21T |
| PT Siloam International Hospitals Tbk | 13.09T |
| PT Mitra Keluarga Karyasehat Tbk | 5.45T |
| PT Millennium Pharmacon International Tbk | 4.15T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.64T |
| PT Phapros Tbk | 961.30B |
| PT Royal Prima Tbk | 329.89B |
| PT Diagnos Laboratorium Utama Tbk | 171.06B |